CHBOF (China Health Technology Group Holding Co) 3-Year ROIIC % : -1.92% (As of Jun. 2025)


CHBOF China Health Technology Group Holding Co Ltd CHBOF
25 GF Score
Price $0.03
GF Value $0.05
! 7 Warning Signs
View Full Analysis

What is China Health Technology Group Holding Co 3-Year ROIIC %?

China Health Technology Group Holding Co CHBOF 25 3-Year ROIIC % is -1.92 as of Jun. 2025. GuruFocus rates CHBOF with a GF Score™ of 25/100 and a GF Value™ of $0.05. The stock has 7 warning signs investors should review. Among 268 Forest Products companies, China Health Technology Group Holding Co ranks worse than 52.99% on this metric.

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. China Health Technology Group Holding Co's 3-Year ROIIC % for the quarter that ended in Jun. 2025 was -1.92%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for China Health Technology Group Holding Co's 3-Year ROIIC % or its related term are showing as below:

CHBOF's 3-Year ROIIC % is ranked worse than
52.99% of 268 companies
in the Forest Products industry
Industry Median: -0.705 vs CHBOF: -1.92

China Health Technology Group Holding Co  (OTCPK:CHBOF) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


China Health Technology Group Holding Co 3-Year ROIIC % Related Terms


China Health Technology Group Holding Co 3-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for China Health Technology Group Holding Co's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Technology Group Holding Co 3-Year ROIIC % Chart

China Health Technology Group Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Jun22 Jun23 Jun24 Jun25
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.21 0.38 5.44 -4.25 -1.92

China Health Technology Group Holding Co Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -4.25 0.00 -1.92 0.00

CHBOF vs SSD, UFPI, BCC: 3-Year ROIIC % Comparison

For the Lumber & Wood Production subindustry, China Health Technology Group Holding Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Technology Group Holding Co 3-Year ROIIC % vs Forest Products Industry

For the Forest Products industry and Basic Materials sector, China Health Technology Group Holding Co's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where China Health Technology Group Holding Co's 3-Year ROIIC % falls into.


CHBOF
25GF Score
China Health Technology Group Holding Co Ltd CHBOF
3-Year ROIIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Health Technology Group Holding Co 3-Year ROIIC % Calculation

China Health Technology Group Holding Co's 3-Year ROIIC % for the quarter that ended in Jun. 2025 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -1.144108 (Jun. 2025) - -1.749 (Jun. 2022) )/( 23.698 (Jun. 2025) - 55.154 (Jun. 2022) )
=0.604892/-31.456
=-1.92%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 3-Year ROIIC % →
What does a 3-Year ROIIC % of -1.92 mean?
China Health Technology Group Holding Co (CHBOF) has a 3-Year ROIIC % of -1.92 as of Jun. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on China Health Technology Group Holding Co and its competitors. According to the industry distribution chart, China Health Technology Group Holding Co ranks #142 out of 268 companies in the Forest Products industry, placing it in the top 53%.
Is China Health Technology Group Holding Co's 3-Year ROIIC % too high?
China Health Technology Group Holding Co's current 3-Year ROIIC % is -1.92. Based on the distribution chart, China Health Technology Group Holding Co ranks #142 out of 268 companies in the Forest Products industry, which is below the industry midpoint. Overall, China Health Technology Group Holding Co has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's 3-Year ROIIC % compare to SSD and UFPI?
According to the Forest Products industry distribution chart, China Health Technology Group Holding Co ranks #142 out of 268 companies for 3-Year ROIIC %. This places China Health Technology Group Holding Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Forest Products company?
A good 3-Year ROIIC % depends on the Forest Products industry context. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on China Health Technology Group Holding Co and its competitors. China Health Technology Group Holding Co's current 3-Year ROIIC % is -1.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current 3-Year ROIIC % of -1.92. The stock's GF Value™ is $0.05, compared to a current price of $0.03 — trading 34.1% below its estimated fair value. The current 3-Year ROIIC % is -1.92. China Health Technology Group Holding Co's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current 3-Year ROIIC % is -1.92 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?

Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued. The current stock price of $0.03 is trading 34.1% below its estimated GF Value™ of $0.05.

Key valuation signals for CHBOF:

  • 3-Year ROIIC %: -1.92
  • GF Value™: $0.05 vs. price of $0.03 (34.1% below fair value)
  • GF Score™: 25/100 with 7 warning signs

No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Health Technology Group Holding Co Business Description

Other Exchanges 01069:Hong Kong
Address South Binhe Avenue, Room 4903, Building A, West Tower, C Future City, Futian District, Shenzhen, CHN
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
25GF Score

Get the complete analysis for CHBOF

3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price
$0.05
GF Value